
Edwards Lifesciences Corporation EW
$ 78.2
0.0%
Annual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Total Non Current Liabilities 2011-2026 | EW
Annual Total Non Current Liabilities Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 1.44 B | 1.31 B | 1.34 B | 1.36 B | 1.08 B | 898 M | 820 M | 395 M | 307 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 B | 307 M | 993 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 291.94 | -1.36 % | $ 8.24 B | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 38.89 | -1.49 % | $ 5.8 K | ||
|
Align Technology
ALGN
|
184 M | $ 186.76 | 0.12 % | $ 14 B | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 12.39 | -2.09 % | $ 1.67 B | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.62 | 4.78 % | $ 38.6 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.59 | 1.85 % | $ 134 M | ||
|
LENSAR
LNSR
|
3.44 M | $ 6.01 | -3.84 % | $ 71.9 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 64.29 | -0.5 % | $ 95.2 B | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 10.45 | -0.14 % | $ 296 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
8.87 K | $ 25.88 | 0.66 % | $ 219 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
1.76 M | $ 2.8 | 2.19 % | $ 7.77 M | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Stryker Corporation
SYK
|
13 B | $ 339.44 | -0.53 % | $ 130 B | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.42 | -2.44 % | $ 409 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 93.7 | -0.9 % | $ 12.7 B | ||
|
Tactile Systems Technology
TCMD
|
14.1 M | $ 25.31 | -0.16 % | $ 579 M | ||
|
TELA Bio
TELA
|
30.2 M | $ 0.67 | 3.04 % | $ 31.5 M | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 1.93 | -0.52 % | $ 1.17 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
TransMedics Group
TMDX
|
34.5 M | $ 111.72 | -3.78 % | $ 3.8 B | ||
|
Tandem Diabetes Care
TNDM
|
31.7 M | $ 20.43 | -1.11 % | $ 1.39 B | ||
|
Inogen
INGN
|
52.5 M | $ 6.19 | -0.16 % | $ 165 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.03 | -0.96 % | $ 17.4 M | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 10.79 | -1.82 % | $ 387 M | ||
|
Inspire Medical Systems
INSP
|
24.6 M | $ 56.65 | 0.02 % | $ 1.66 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 39.15 | -0.74 % | $ 1.22 B |